Bioactive Oxadiazoles 2.0
Funding
Conflicts of Interest
References
- Świątek, P.; Glomb, T.; Dobosz, A.; Gębarowski, T.; Wojtkowiak, K.; Jezierska, A.; Panek, J.J.; Świątek, M.; Strzelecka, M. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide. Int. J. Mol. Sci. 2022, 23, 549. [Google Scholar] [CrossRef] [PubMed]
- Peregrym, K.; Szczukowski, Ł.; Wiatrak, B.; Potyrak, K.; Czyżnikowska, Ż.; Świątek, P. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone as Promising Cyclooxygenase Inhibitors. Int. J. Mol. Sci. 2021, 22, 9130. [Google Scholar] [CrossRef] [PubMed]
- Sava, A.; Buron, F.; Routier, S.; Panainte, A.; Bibire, N.; Constantin, S.M.; Lupașcu, F.G.; Focșa, A.V.; Profire, L. Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-Oxadiazole-2-thiol Scaffold. Int. J. Mol. Sci. 2021, 22, 7079. [Google Scholar] [CrossRef] [PubMed]
- Glomb, T.; Świątek, P. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives. Int. J. Mol. Sci. 2021, 22, 6979. [Google Scholar] [CrossRef] [PubMed]
- Paruch, K.; Biernasiuk, A.; Berecka-Rycerz, A.; Hordyjewska, A.; Popiołek, Ł. Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Int. J. Mol. Sci. 2021, 22, 13669. [Google Scholar] [CrossRef] [PubMed]
- Liu, D.; Luo, L.; Wang, Z.; Ma, X.; Gan, X. Design, Synthesis and Antifungal/Nematicidal Activity of Novel 1,2,4-Oxadiazole Derivatives Containing Amide Fragments. Int. J. Mol. Sci. 2022, 23, 1596. [Google Scholar] [CrossRef] [PubMed]
- Marzullo, P.; Vasto, S.; Buscemi, S.; Pace, A.; Nuzzo, D.; Palumbo Piccionello, A. Ammonium Formate-Pd/C as a New Reducing System for 1,2,4-Oxadiazoles. Synthesis of Guanidine Derivatives and Reductive Rearrangement to Quinazolin-4-Ones with Potential Anti-Diabetic Activity. Int. J. Mol. Sci. 2021, 22, 12301. [Google Scholar] [CrossRef] [PubMed]
- Chugunova, E.; Gazizov, A.; Islamov, D.; Burilov, A.; Tulesinova, A.; Kharlamov, S.; Syakaev, V.; Babaev, V.; Akylbekov, N.; Appazov, N.; et al. The Reactivity of Azidonitrobenzofuroxans towards 1,3-Dicarbonyl Compounds: Unexpected Formation of Amino Derivative via the Regitz Diazo Transfer and Tautomerism Study. Int. J. Mol. Sci. 2021, 22, 9646. [Google Scholar] [CrossRef] [PubMed]
- Chugunova, E.; Micheletti, G.; Telese, D.; Boga, C.; Islamov, D.; Usachev, K.; Burilov, A.; Tulesinova, A.; Voloshina, A.; Lyubina, A.; et al. Novel Hybrid Compounds Containing Benzofuroxan and Aminothiazole Scaffolds: Synthesis and Evaluation of Their Anticancer Activity. Int. J. Mol. Sci. 2021, 22, 7497. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Palumbo Piccionello, A. Bioactive Oxadiazoles 2.0. Int. J. Mol. Sci. 2022, 23, 3841. https://doi.org/10.3390/ijms23073841
Palumbo Piccionello A. Bioactive Oxadiazoles 2.0. International Journal of Molecular Sciences. 2022; 23(7):3841. https://doi.org/10.3390/ijms23073841
Chicago/Turabian StylePalumbo Piccionello, Antonio. 2022. "Bioactive Oxadiazoles 2.0" International Journal of Molecular Sciences 23, no. 7: 3841. https://doi.org/10.3390/ijms23073841